Sartorius (OTCMKTS:SARTF) Stock Price Up 2.3% – What’s Next?

Sartorius (OTCMKTS:SARTF) shares shot up 2.3% during trading on Monday . The company traded as high as $225.00 and last traded at $225.00. 4 shares traded hands during trading, an increase of 7,900% from the average session volume of 0 shares. The stock had previously closed at $220.00.

Sartorius Price Performance

The firm’s fifty day moving average is $212.76 and its two-hundred day moving average is $201.00. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49.

Sartorius (OTCMKTS:SARTF) last released its earnings results on Thursday, October 16th. The company reported $1.26 EPS for the quarter, beating the consensus estimate of $1.25 by $0.01. The firm had revenue of $987.65 million for the quarter, compared to analysts’ expectations of $972.82 million. Sartorius had a net margin of 3.82% and a return on equity of 8.19%.

About Sartorius

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.